EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Left Ventricular and Right Ventricular Hypertrophy Modelling to Study PAPP-A-Mediated IGFBP-4 Cleavage-a Mechanism That Regulates IGF Bioavailability in Adult Rats

Marina M Artemieva, Arina V Makeeva, Daria A Adasheva iD, Viacheslav E Shein, Alexey G Katrukha, Alexander B Postnikov, Natalia A Medvedeva, Daria V Serebryanaya

International Journal of Molecular Sciences · 18.03.2026 · 27 (6) · 2761

DOI: 10.3390/ijms27062761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.03.2026. Verfasst von Marina M Artemieva und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology, Lomonosov Moscow State University, 119992 Moscow, Russia. Hauptthemen laut MEDLINE: Pregnancy-Associated Plasma Protein-A, Insulin-Like Growth Factor Binding Protein 4, Hypertrophy, Left Ventricular, Hypertrophy, Right Ventricular. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian State Foundation Grant, Russian Science Foundation, Lomonosov Moscow State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological cardiac hypertrophy, a major contributor to heart failure, is characterized by an abnormal increase in the size of atria and ventricles. In the context of ventricular hypertrophy, the right ventricle (RV) exhibits less resistance to hypertrophy than the left one (LV). Insulin-like growth factors (IGF-1 and IGF-2) are critical for cell growth and provide cardioprotective effects. Pregnancy-associated plasma protein-A (PAPP-A) is a protease that cleaves insulin-like growth factor-binding protein-4 (IGFBP-4) and enhances IGF bioavailability. This study investigated PAPP-A-mediated IGFBP-4 proteolysis—one possible mechanism of IGF release regulation in rat models of right ventricular (RVH) and left ventricular (LVH) hypertrophy. RVH was induced with monocrotaline, and LVH via renovascular hypertension (1 Kidney 1 Clip (1K1C) model). Systolic blood pressure was measured using tail-cuff plethysmography. Heart morphometry was used to assess the mass of cardiac chambers. Cardiomyocyte purity was confirmed via troponin I immunocytochemistry. Plasma natriuretic type-B peptide (BNP) and C-terminal IGFBP-4 (CT-IGFBP-4) concentrations were quantified by fluoroimmunoassay. RVH and LVH were successfully modelled, with 1.6-fold and 1.3-fold increases in RV (p < 0.0001) and LV masses (p < 0.05), respectively. Plasma BNP was 2–3 times higher in LVH versus control rats. Hypertrophied cardiomyocytes secreted significantly more BNP than controls, showing 3.3-fold and 4.1-fold increases in LVH and RVH, respectively. PAPP-A-mediated IGFBP-4 proteolysis was 4-fold higher in RVH compared to control, but unaffected in LVH. These findings suggest that PAPP-A-specific elevation of IGFBP-4 proteolysis occurs predominantly in RVH, suggesting a differential IGF bioavailability in both ventricles and highlighting PAPP-A as a potential target to increase RVH resistance to hypertrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy-Associated Plasma Protein-AInsulin-Like Growth Factor Binding Protein 4Hypertrophy, Left VentricularHypertrophy, Right VentricularInsulin-Like Growth Factor IInsulin-Like PeptidesAnimalsRatsMaleDisease Models, AnimalProteolysisRats, Sprague-DawleyHeart VentriclesMyocytes, Cardiac

Stichwörter der Autor:innen

PAPP-A-mediated IGFBP-4 proteolysiscardiac hypertrophypulmonary hypertensionrenovascular hypertension

Substanzen

Pregnancy-Associated Plasma Protein-AInsulin-Like Growth Factor Binding Protein 4Insulin-Like Growth Factor IInsulin-Like Peptides

Autor:innen und Institutionen

  • School of Biology, Lomonosov Moscow State University, 119992 Moscow, Russia.
  • HyTest, Ltd., 20520 Turku, Finland.
  • Institute of Neuroscience and Neurotechnology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.

ORCID-Profile: Daria A Adasheva

Förderung

  • Russian State Foundation Grant
  • Russian Science Foundation
  • Lomonosov Moscow State University

Zitieren

APA

Artemieva, M. M., Makeeva, A. V., Adasheva, D. A., Shein, V. E., Katrukha, A. G., Postnikov, A. B., Medvedeva, N. A., & Serebryanaya, D. V. (2026). Left Ventricular and Right Ventricular Hypertrophy Modelling to Study PAPP-A-Mediated IGFBP-4 Cleavage-a Mechanism That Regulates IGF Bioavailability in Adult Rats. International Journal of Molecular Sciences, 27(6), 2761. https://doi.org/10.3390/ijms27062761

Vancouver

Artemieva MM, Makeeva AV, Adasheva DA, Shein VE, Katrukha AG, Postnikov AB, et al. Left Ventricular and Right Ventricular Hypertrophy Modelling to Study PAPP-A-Mediated IGFBP-4 Cleavage-a Mechanism That Regulates IGF Bioavailability in Adult Rats. International Journal of Molecular Sciences. 2026;27(6):2761. doi:10.3390/ijms27062761

BibTeX
@article{Artemieva2026,
  author = {Artemieva, Marina M and Makeeva, Arina V and Adasheva, Daria A and Shein, Viacheslav E and Katrukha, Alexey G and Postnikov, Alexander B and Medvedeva, Natalia A and Serebryanaya, Daria V},
  title = {Left Ventricular and Right Ventricular Hypertrophy Modelling to Study PAPP-A-Mediated IGFBP-4 Cleavage-a Mechanism That Regulates IGF Bioavailability in Adult Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2761},
  doi = {10.3390/ijms27062761}
}
Kostenlos starten →